Corcept Therapeutics Incorporated Total Shareholders Equity 2011-2026 | CORT

Annual Total Shareholders Equity Corcept Therapeutics Incorporated

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
648 M	680 M	507 M	502 M	376 M	523 M	371 M	276 M	191 M	41.4 M	18.5 M	-3.39 M	21 M	61.8 M	34.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
680 M	-3.39 M	283 M

Quarterly Total Shareholders Equity Corcept Therapeutics Incorporated

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
632 M	636 M	683 M	639 M	596 M	548 M	462 M	422 M	530 M	-	473 M	442 M	408 M	376 M	540 M	523 M	511 M	523 M	523 M	523 M	523 M	371 M	371 M	371 M	371 M	276 M	276 M	276 M	276 M	191 M	191 M	191 M	191 M	41.4 M	41.4 M	41.4 M	41.4 M	18.5 M	18.5 M	18.5 M	18.5 M	-3.39 M	-3.39 M	-3.39 M	-3.39 M	21 M	21 M	21 M	21 M	61.8 M	61.8 M	61.8 M	61.8 M	34.8 M	34.8 M	34.8 M	34.8 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
683 M	-3.39 M	260 M

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	621 M	-	2.43 %	$ 254 M	Germany
Advaxis ADXS	-24.4 M	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	234 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	169 M	-	-	$ 28.6 M	USA
AlloVir ALVR	78.8 M	-	4.14 %	$ 49.1 M	USA
I-Mab IMAB	1.72 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	715 M	-	-	$ 1.01 B	USA
Ampio Pharmaceuticals AMPE	3.36 M	-	-11.43 %	$ 502 K	USA
Midatech Pharma plc MTP	6.72 M	-	-18.52 %	$ 27.3 M	Britain
Applied Molecular Transport AMTI	60.8 M	-	-	$ 10.1 M	USA
Applied Therapeutics APLT	-17.1 M	-	-	$ 8.42 M	USA
Aptorum Group Limited APM	23.1 M	$ 0.9	-0.02 %	$ 6.62 M	China
Biophytis SA BPTS	2.27 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	-16.2 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	733 M	$ 22.46	0.72 %	$ 3.72 B	USA
Aptinyx APTX	38.3 M	-	-39.0 %	$ 4.57 M	USA
Ayala Pharmaceuticals AYLA	-1.1 M	-	-	$ 7.46 M	Israel
Brainstorm Cell Therapeutics BCLI	-9.98 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	188 M	-	-4.8 %	$ 255 M	USA
AIkido Pharma AIKI	69.4 M	-	1.93 %	$ 17.4 M	USA
Cara Therapeutics CARA	20.9 M	-	-3.03 %	$ 260 M	USA
CASI Pharmaceuticals CASI	84.5 M	-	-	$ 35.4 M	USA
Fennec Pharmaceuticals FENC	35.5 M	$ 6.81	-0.58 %	$ 195 M	USA
ChromaDex Corporation CDXC	76.5 M	-	-0.88 %	$ 598 M	USA
Galectin Therapeutics GALT	-128 M	$ 2.37	-0.04 %	$ 151 M	USA
AgeX Therapeutics AGE	-37 K	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	10.7 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	-24.2 M	-	17.91 %	$ 11.1 M	USA
Greenwich LifeSciences GLSI	2.53 M	$ 23.76	-0.96 %	$ 309 M	USA
BioNTech SE BNTX	1.37 B	$ 101.26	-0.78 %	$ 27.2 B	Germany
Checkpoint Therapeutics CKPT	-12.6 M	-	-	$ 169 M	USA
Avenue Therapeutics ATXI	1.83 M	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	29.5 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	-33.7 M	$ 4.14	1.1 %	$ 443 M	USA
Arcutis Biotherapeutics ARQT	189 M	$ 23.67	1.07 %	$ 3.01 B	USA
Heron Therapeutics HRTX	14.3 M	$ 1.19	0.01 %	$ 198 M	USA
Autolus Therapeutics plc AUTL	178 M	$ 1.45	2.13 %	$ 386 M	Britain
Aptose Biosciences APTO	-27.2 M	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	15.6 B	-	-	$ 96.9 B	Britain
AVROBIO AVRO	94.7 M	-	1083.1 %	$ 745 M	USA
InflaRx N.V. IFRX	77.9 M	$ 1.81	12.11 %	$ 152 M	Germany
Can-Fite BioPharma Ltd. CANF	5.59 M	$ 2.98	2.05 %	$ 4.91 M	Israel
BeiGene, Ltd. BGNE	4.36 B	-	0.49 %	$ 251 B	Cayman-islands
Inventiva S.A. IVA	111 M	$ 5.14	0.19 %	$ 138 M	France
Akero Therapeutics AKRO	750 M	-	-	$ 3.67 B	USA
bluebird bio BLUE	195 M	-	-	$ 546 M	USA